行情

ASXC

ASXC

Asensus Surgical Inc
AMEX

实时行情|Nasdaq Last Sale

1.970
+0.040
+2.07%
交易中 11:27 09/23 EDT
开盘
1.960
昨收
1.930
最高
1.980
最低
1.870
成交量
137.80万
成交额
--
52周最高
6.95
52周最低
0.3344
市值
4.62亿
市盈率(TTM)
-4.5996
分时
5日
1月
3月
1年
5年
Asensus Surgical, Inc. 将参加三场即将举行的虚拟医疗会议
RESEARCH TRIANGLE PARK, N.C., September 08, 2021--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will p...
Business Wire · 09/08 10:55
BRIEF-Asensus Surgical Receives FDA 510(K) Clearance For Expansion Of Machine Vision Capabilities
reuters.com · 09/01 12:39
Asensus Surgical 获得 FDA 510(k) 许可,用于扩展机器视觉功能
RESEARCH TRIANGLE PARK, N.C., September 01, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced t...
Business Wire · 09/01 12:00
Asensus 获得 FDA 批准,以扩展手术平台的机器视觉功能
MT Newswires · 09/01 10:20
早盘市场更新:市场开盘走低;沃尔玛利润高于预期
Following the market opening Tuesday, the Dow traded down 0.67% to 35,385.44 while the NASDAQ fell 0.79% to 14,676.74. The S&P also fell, dropping 0.54% to 4,455.32.
Benzinga · 08/17 14:32
55 只股票在周五的午盘交易中移动
Gainers
Benzinga · 08/06 16:00
Expedia Group、Novavax、Zynga 是上市前的失败者
Spectrum Pharmaceuticals SPPI -35% after FDA declines to approve ROLONTIS Dicerna Pharmaceuticals DRNA -28% slide despite pivotal nedosiran study hitting primary endpoint Zynga ZNGA -16% on Q2 earnings release Chembio Diagnostics CEMI -13% on Q2 earnings r...
Seekingalpha · 08/06 12:43
Asensus Surgical (ASXC) 报告第二季度亏损,未达到收入预期
Zacks.com · 08/05 23:15
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解ASXC最新的财务预测,通过ASXC每股收益,每股净资产,每股现金流等数据分析Asensus Surgical Inc近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测ASXC价格均价为4.000,最高价位4.000,最低价为4.000。
EPS
机构持股
总机构数: 157
机构持股: 7,336.31万
持股比例: 31.31%
总股本: 2.34亿
类型机构数股数
增持
45
690.50万
建仓
19
221.09万
减持
31
1,131.62万
平仓
24
140.49万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
+0.83%
医疗设备和用品
+0.56%
高管信息
Non-Executive Chairman/Independent Director
Paul LaViolette
President/Chief Executive Officer/Director
Anthony Fernando
Chief Financial Officer/Executive Vice President
Shameze Rampertab
Independent Director
Andrea Biffi
Independent Director
Kevin Hobert
Independent Director
Jane Hsiao
Independent Director
Elizabeth Kwo
Independent Director
David Milne
Independent Director
Richard Pfenniger
Independent Director
William Starling
暂无数据
ASXC 简况
Asensus Surgical, Inc., formerly TransEnterix, Inc., is a medical device company. The Company is engaged in digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through digital laparoscopy. The Senhance system is a machine vision system for use in robotic surgery, which is powered by intelligent surgical unit that enables augmented intelligence in surgery. Its System is designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, advanced instrumentation, including three-millimeter micro laparoscopic instruments, eye-sensing camera control and reusable standard instruments to patients around the world. The Senhance System is used in Europe for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.

微牛提供Asensus Surgical Inc(AMEX-ASXC)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ASXC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ASXC股票基本功能。